Company: DAWN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026654
Chunk: 8

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 15
Chunk 8
---
1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    X

    32.1**
     
    Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    X

    97.1
     
    Compensation Recovery Policy

    X

    101.INS
     
    Inline XBRL Instance Document

    X

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document

    X

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.

    X

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.

    X

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document.

    X

    101.PRE  
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.

    X

    104
     
    Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit 101)

    X

† 	Registrant has omitted portions of the exhibit as permitted under Item 601(b)(10) of Regulations S-K.
^ 	Indicates management contract or compensatory plan.

130

* 	Registrant has omitted schedules and exhibits pursuant to Item 601(a)(5) of Regulation S-K. The Registrant agrees to furnish supplementally a copy of the omitted schedules and exhibits to the SEC upon request

**	This certification is deemed not filed for purposes of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.